Supplementary Figure 1 from Recommendations for Validating Omics Prediction Models: Insights from a Lung Cancer RNA Biomarker Study
Luca Pestarino(Oslo University Hospital), Trine B. Rounge(Oslo University Hospital), Renée T. Fortner(Norwegian Institute of Public Health), Therese Haugdahl Nøst(UiT The Arctic University of Norway), Hilde Langseth(Cancer Registry of Norway), Ilona Urbárová(UiT The Arctic University of Norway), Ioannis Fotopoulos(University of Crete), Oluf Dimitri Røe(Norwegian University of Science and Technology)
Cited by 0
Related Papers
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
|Journal of Clinical Oncology|2016|517
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies
|The Lancet Oncology|2013|403
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
|European Journal of Cancer|2015|279
Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study
|BMC Pregnancy and Childbirth|2016|245
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229